Literature DB >> 21762250

T-wave alternans and heart rate variability: a comparison in patients with myocardial infarction with or without diabetes mellitus.

LiNa Ren1, XinHui Fang, Yongquan Wang, Guoxian Qi.   

Abstract

BACKGROUND: The aim of this study was to investigate the differences in T-wave alternans (TWA) and heart rate variability (HRV) among patients with myocardial infarction with or without diabetes mellitus and the relationship between TWA and HRV.
METHODS: The study population included 133 patients: 59 patients with myocardial infarction (MI) (group post-MI without diabetes); 40 myocardial infarction with diabetes (group post-MI with diabetes); and 34 controls (group control). Cardiac autonomic neuropathy assessment was made using frequency domain (low-frequency [LF] power, high-frequency [HF] power, LF/HF) and time domain (SDNN, standard deviation of the averaged normal sinus RR intervals for all 5-minute segments [SDANN]) of HRV indexes. Both TWA and HRV were measured on the Holter monitor, and TWA was calculated automatically using the time-domain modified moving average method.
RESULTS: TWA values differed significantly between controls (40 ± 16 μV) and group post-MI with (62 ± 17 μV, P < 0.05) or without (60 ± 15 μV, P < 0.05) diabetes. In addition, group post-MI with diabetes had lower standard deviation of all normal sinus RR intervals (SDNN), standard deviation of the averaged normal sinus RR intervals for all 5-minute segments (SDANN), and HF, indicating depressed vagus nerve activity, and higher LF/HF ratio, indicating elevated sympathetic nerve activity, than controls and group post-MI without diabetes (P < 0.05). TWA correlated with SDNN and SDANN (r = 0.29, 0.31; P < 0.001).
CONCLUSIONS: TWA was elevated in patients following myocardial infarction, both in those with or without diabetes. Myocardial infarction patients had a lower time domain, HF, and a higher LF/HF ratio HRV, especially in those with diabetes. The analysis of modified moving agerage (MMA)-based TWA and HRV can be a useful tool for identifying post-myocardial infarction patients at high risk of arrhythmic events. ©2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21762250      PMCID: PMC6932405          DOI: 10.1111/j.1542-474X.2011.00437.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  33 in total

1.  Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.

Authors:  Takanori Ikeda; Hideaki Yoshino; Kaoru Sugi; Kaoru Tanno; Hiroki Shimizu; Jun Watanabe; Yuji Kasamaki; Akihiro Yoshida; Takao Kato
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

Review 2.  T-wave alternans and the susceptibility to ventricular arrhythmias.

Authors:  Sanjiv M Narayan
Journal:  J Am Coll Cardiol       Date:  2006-01-04       Impact factor: 24.094

3.  Frequency domain measures of heart period variability and mortality after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R C Steinman; L M Rolnitzky; R E Kleiger; J N Rottman
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

4.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.

Authors:  M T La Rovere; J T Bigger; F I Marcus; A Mortara; P J Schwartz
Journal:  Lancet       Date:  1998-02-14       Impact factor: 79.321

5.  Assessment of autonomic function in humans by heart rate spectral analysis.

Authors:  B Pomeranz; R J Macaulay; M A Caudill; I Kutz; D Adam; D Gordon; K M Kilborn; A C Barger; D C Shannon; R J Cohen
Journal:  Am J Physiol       Date:  1985-01

6.  The value of cardiovascular autonomic function tests: 10 years experience in diabetes.

Authors:  D J Ewing; C N Martyn; R J Young; B F Clarke
Journal:  Diabetes Care       Date:  1985 Sep-Oct       Impact factor: 19.112

7.  Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.

Authors:  Daniel M Bloomfield; Richard C Steinman; Pearila B Namerow; Michael Parides; Jorge Davidenko; Elizabeth S Kaufman; Timothy Shinn; Anne Curtis; John Fontaine; Douglas Holmes; Andrea Russo; Chuen Tang; J Thomas Bigger
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

Review 8.  Sudden cardiac death in patients with diabetes.

Authors:  Fadi A El-Atat; Samy I McFarlane; James R Sowers; J Thomas Bigger
Journal:  Curr Diab Rep       Date:  2004-06       Impact factor: 4.810

9.  T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test.

Authors:  Tuomo Nieminen; Terho Lehtimäki; Jari Viik; Rami Lehtinen; Kjell Nikus; Tiit Kööbi; Kari Niemelä; Väinö Turjanmaa; Willi Kaiser; Heini Huhtala; Richard L Verrier; Heikki Huikuri; Mika Kähönen
Journal:  Eur Heart J       Date:  2007-07-25       Impact factor: 29.983

10.  Heart rate variability as an indicator of left ventricular systolic dysfunction.

Authors:  Abdullah Shehab; Asim A Elnour; Allan D Struthers
Journal:  Cardiovasc J Afr       Date:  2009 Sep-Oct       Impact factor: 1.167

View more
  5 in total

Review 1.  Cardiac alternans and intracellular calcium cycling.

Authors:  Joshua N Edwards; Lothar A Blatter
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-07       Impact factor: 2.557

2.  In-hospital heart rate turbulence and microvolt T-wave alternans abnormalities for prediction of early life-threatening ventricular arrhythmia after acute myocardial infarction.

Authors:  Mohamed Moussa Arisha; Nicolas Girerd; Samuel Chauveau; Didier Bresson; Alina Scridon; Eric Bonnefoy; Philippe Chevalier
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-10-23       Impact factor: 1.468

3.  Antidiabetic activity of mefloquine via GLP-1 receptor modulation against STZ-NA-induced diabetes in albino wistar rats.

Authors:  Mohd Nazam Ansari; Abdulaziz S Saeedan; Rajnish Kumar Yadav; Jitendra K Rawat; Swetlana Gautam; Manjari Singh; Manish Kumar; Subhadeep Roy; Gaurav Kaithwas
Journal:  3 Biotech       Date:  2018-05-04       Impact factor: 2.406

4.  Changes of Virtual Planar QRS and T Vectors Derived from Holter in the Populations with and without Diabetes Mellitus.

Authors:  Jia Chen; Yubi Lin; Jian Yu; Wanqun Chen; Zhe Xu; Zhenzhen Yang; Chuqian Zeng; Wenfeng Li; Xiaoshu Lai; Qiji Lu; Jingwen Zhou; Bixia Tian; Jing Xu; Yanping Lin; Zuoyi Du; Aidong Zhang
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-05-04       Impact factor: 1.468

5.  Ambulatory ECG-based T-wave alternans and heart rate turbulence can predict cardiac mortality in patients with myocardial infarction with or without diabetes mellitus.

Authors:  Ren Li-na; Fang Xin-hui; Ren Li-dong; Gong Jian; Wang Yong-quan; Qi Guo-xian
Journal:  Cardiovasc Diabetol       Date:  2012-09-06       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.